• Correction: Hospital Superbug Outbreak story

    LOS ANGELES (AP) — In a Feb. 20, 2015 story about an antibiotic-resistant “superbug” outbreak at Ronald Reagan UCLA Medical Center, The Associated Press mischaracterized a statement an expert made about proving the cause of an infection. Lawrence Muscarella, a health care and sterilization expert, said he was suggesting an argument hospitals might use when he said, “Proving causation is impossible.” Muscarella said an infection can be proven to come from a hospital instrument.

  • "Sister Paula was an angel," says Joe Morgan Jr., of Lexington, Miss., Friday, Aug. 26, 2016, standing at a businesses adjacent to the Lexington Medical Clinic where he was a patient of Sister Paula Merrill, one of two nurse practitioners who were found slain Thursday in their Durant, Miss., home, a few miles away. Merrill and Sister Margaret Held, were known for their kindness and community involvement in the mostly rural Mississippi Delta towns.  (AP Photo/Rogelio V. Solis)

    Killing of 2 nuns leaves gaping hole in poor community

    LEXINGTON, Miss. (AP) — In the poverty-stricken Mississippi county where two nuns were slain, forgiveness for their killer is hard to find, even if forgiveness is what the victims would have wanted.

  • Correction: Congress-EpiPens-Manchin story

    CHARLESTON, W.Va. (AP) — In a story Aug. 24 about U.S. Sen. Joe Manchin’s stance on price hikes for life-saving allergy injection pens, The Associated Press erroneously reported that the cost of a two-dose package of EpiPens rose more than 600 percent in the last nine years. The price rise reflects an increase of more than 500 percent.

  • This Oct. 10, 2013, file photo, shows an EpiPen epinephrine auto-injector, a Mylan product, in Hendersonville, Texas. Mylan, now in the crosshairs over severe price hikes for its EpiPen, said Thursday, Aug. 25, 2016, it will expand programs that lower out-of-pocket costs by as much as half. (AP Photo/Mark Zaleski, File)

    Mylan boosts EpiPen patient programs, doesn’t budge on price

    The maker of EpiPens offered patients more help to pay for its costly emergency allergy shots but didn’t budge Thursday on the $608 price.

  • In this Friday, July 8, 2016 photo, a pharmacist holds a package of EpiPens, an epinephrine autoinjector for the treatment of allergic reactions, in Sacramento, Calif. Price hikes for the emergency medicine have made its maker, Mylan, the latest target for patients and politicians infuriated by soaring drug prices. (AP Photo/Rich Pedroncelli)

    How EpiPen’s maker raised prices, and hackles, so much

    TRENTON, N.J. (AP) — Sky-high price hikes for EpiPen, the injected emergency medicine for severe allergic reactions to foods and bug bites, have made its maker the latest target for patients and politicians infuriated by soaring drug prices.

  • In this Friday, Nov. 13, 2015, file photo, the American flag flies above the Wall Street entrance to the New York Stock Exchange. Stocks were moving mostly lower in early trading Monday, Aug. 22, 2016, as investors looked ahead to the Fed’s meeting in Jackson Hole, Wyo., for clues on timing for possible interest rate hikes. A drop in oil prices pulled energy companies lower, along with the broader market. (AP Photo/Richard Drew, File)

    Stocks fall in early trading as oil prices decline

    HONG KONG (AP) — Most stock markets in Asia moved sideways on Tuesday as the summer doldrums and a lack of economic data ahead of a widely anticipated speech by the Fed chief kept investors on the sidelines.

  • A Emergis emergency room facility sits behind a fence as construction continues, Thursday, Aug. 18, 2016, in Dallas. In just a few short years freestanding emergency centers have sprouted like mushrooms across the suburban landscape, taking root in affluent neighborhoods and directly challenging medical clinics and hospitals that may only be blocks away. (AP Photo/Tony Gutierrez)

    As the number of freestanding ERs grows, so does scrutiny

    DALLAS (AP) — Freestanding emergency centers have sprouted in recent years across the suburban landscape, taking root in affluent neighborhoods and directly challenging nearby medical clinics and hospitals.